SCPH - scPharmaceuticals Quarterly EPS earnings growth
The prospects for scPharmaceuticals Inc. (SCPH) are based on insurance coverage and the adoption rates of Furoscix. The GURU.Markets service features a line chart where the quarterly EPS change visualizes profit dynamics, and 23.00 determines this parameter level. Innovations in subcutaneous drug delivery make the company a key link in medicine, while the pump launch ensures a cash inflow alongside controlled personnel expenses.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_SCPH_-_scPharmaceuticals-Inc._-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "scPharmaceuticals (SCPH): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 10/18/2025 | 👁️GURU.Markets👁️")
Analytical breakdowns and data insights for company scPharmaceuticals (SCPH)
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Total Debt to Capital scPharmaceuticals Inc.|SCPH - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity scPharmaceuticals|SCPH - Company Aggregate Indebtedness|Debts to Book Capitalization scPharmaceuticals Inc.|SCPH - Company Long-Term Loans and Borrowings|Company Short-Term Debts scPharmaceuticals|Quick Liquidity scpharmaceuticals.com
- earnings and market multiples details:
SCPH - Final Profit|Expected Profit scPharmaceuticals Inc.|SCPH - Price to Earnings Ratio|Forward P/E Multiple scPharmaceuticals|SCPH - PEG Multiple|EV/EBITDA Multiple scPharmaceuticals Inc.|SCPH - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) scPharmaceuticals|SCPH - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months scpharmaceuticals.com|SCPH - Earnings growth in current year|Expected earnings per share growth for next year scPharmaceuticals Inc.
- sales revenue and business income indicators:
General company analysis:scpharmaceuticals.com - SCPH
High R&D expenses leave scPharmaceuticals Inc. (SCPH) vulnerable to market shocks. However, the development of wearable pumps and liquid formulations creates a significant technological advantage. This metric assesses the percentage change in net earnings per share per quarter. By analyzing the quarterly EPS growth profile, an investor determines the efficiency of innovation capitalization. A steady upward trend in the curve confirms the company's transition to a profit-scaling phase.
Who scPharmaceuticals Inc. competes with
HLN: Quarterly EPS earnings growth|Kenvue Corp - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma PLC) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jyongbio.com MENS|Year-over-year earnings per share growth for the last twelve months Ligand (LGND)|AMRX (Amneal) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|Quarterly EPS earnings growth Alvotech Biopharmaceuticals ALVO|liquidia.com - Quarterly EPS earnings growth|GLPG - Quarterly EPS earnings growth|ANIP: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months MNKD|AMPH (Amphastar) - Quarterly EPS earnings growth|Pacira Corp (PCRX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months ARS Pharma (SPRY)|Quarterly EPS earnings growth Theravance Biopharma, Inc. (TBPH)|Aquestive Therapeutics - Year-over-year net earnings per share growth for the last 12 months|TECX: Year-over-year earnings per share growth for the last 12 months|TNXP - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months SXT Pharmaceuticals SXTC|EPRX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months bioharvest.com (BHST)|Year-over-year net earnings per share growth for the last 12 months EXOZ|ORMP: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ABVC (ABVC BioPharma, Inc)|Year-over-year earnings per one share growth for the last 12 months CPIX|QNTM - Year-over-year earnings per share growth for the last twelve months|FibroGen Corp (FGEN) - Year-over-year net earnings per share growth for the last 12 months|Telomir Pharmaceuticals Corp (TELO) - Year-over-year earnings per share growth for the last twelve months|Rani Therapeutics (RANI) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Synergy CHC Corp.|Earnings per share growth in annualized terms for the last twelve months rallybio.com RLYB|Quarterly EPS earnings growth LEXX|PULM: Year-over-year net earnings per share trend for the last twelve months|Pheton Holdings Ltd - Year-over-year net earnings per share growth for the last 12 months|APM - Year-over-year net earnings per share growth for the last 12 months|LYRA - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Year-over-year earnings per share growth for the last twelve months|cbdMD Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months PRFX|Altamira Therapeutics (CYTO) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth LIPO|Quarterly EPS earnings growth optinose.com (OPTN)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals, Inc. PIRS|Procaps (PROC) - Earnings per share growth in annualized terms for the last twelve months|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Qilian International Corp QLI|SLRN: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TFFP (tffpharma.com)
